Home
Site Map
Press Room
Press Releases
Contact Us
Clinical Trials
Phase 3 — Hepatocellular Carcinoma (HCC)
Phase 3 — Metastatic Colorectal Cancer (MCRC)
Phase 2 — Benign Prostatic Hyperplasia (BPH)
Phase 1 — Benign Prostatic Hyperplasia (BPH)
Pipeline
Hepatocellular Carcinoma (HCC)
Metastatic Colorectal Cancer (MCRC)
Benign Prostatic Hyperplasia (BPH)
Aptocine™
Aptocine™ Advantages
Publications
The Company
Executive Team
Board of Directors
Careers
Contact LSO
Press Room
Press Releases
Contact Us
Press Releases
View Archive: 2011 |
2010
|
2009
|
2008
|
2007
|
2006
|
2005
May 11, 2011 –
Light Sciences Oncology Elects Dennis Langer, M.D., J.D. to its Board of Directors